Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Bi opsy of the P rostate A voidance S ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

In a biopsy, a small sample of tissue is taken from your body. A pathologist analyzes the sample to check for cancer cells. The main method for diagnosing prostate cancer is a core needle biopsy. It’s ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...

The FDA has granted Cleveland Diagnostics’ IsoPSA test premarket approval (PMA) to help detect prostate cancer in men aged 50 years or older with elevated PSA levels. IsoPSA is a blood assay that ...

The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced. Dubbed IsoPSA, the in vitro diagnostic kit is ...

A breakdown of rare and lesser-known cosmetic procedures from around the world, and why people choose them. Appeals court upholds $1M penalty against Trump in lawsuit against Hillary Clinton Guy Fieri ...

Source: Getty Images Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection. Serum PSA testing is not specific to prostate cancer, and ...

The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...

If you're experiencing symptoms that may indicate prostate cancer, here's what else could be causing them getty Several medical conditions can mimic prostate cancer, causing many of the same symptoms, ...